Drug profile · INN
emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)
EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN"
- Patents linked
- 0
- News articles
- 0
Quick answer
emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype) (EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN") is an FDA-listed pharmaceutical active ingredient.
Key facts
Frequently asked questions
What is emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)?
emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype) (EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN") is an FDA-listed pharmaceutical active ingredient.
What is the brand name for emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)?
EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN" is a marketed brand name for emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype). Check FDA Drugs@FDA for the current US label holder and prescribing information.